Company Filing History:
Years Active: 2012-2020
Title: **The Innovative Contributions of Susannah Karen Ford**
Introduction
Susannah Karen Ford is a notable inventor based in Stevenage, GB. With a remarkable portfolio of 11 patents, she has made significant contributions to the field of biomedical research and pharmaceutical development. Her groundbreaking work focusing on antigen binding proteins has paved the way for advancements in treating various diseases.
Latest Patents
Among her most recent patents is the development of antigen binding proteins that target oncostatin M (OSM). This invention encompasses proteins and fragments that specifically bind to human OSM, inhibiting its interaction with the gp130 receptor without directly engaging with site II residues. Additionally, her innovation includes a method for humanizing antibodies, which can enhance therapeutic efficacy. Another notable patent pertains to antigen binding proteins that interact with the serum amyloid P component (SAP). These proteins, along with their encoding polynucleotides and pharmaceutical compositions, contribute significantly to the treatment and prevention of diseases linked to amyloid deposition, such as systemic amyloidosis, local amyloidosis, Alzheimer's disease, and type 2 diabetes.
Career Highlights
Susannah is currently associated with Glaxo Group Limited, a prominent player in the pharmaceutical industry. Her career reflects a strong commitment to innovative research, leading to practical applications in medical therapies. The impact of her work in the field highlights her as a proactive contributor to advancements in healthcare.
Collaborations
Throughout her career, Susannah has collaborated with talented colleagues, including Volker Germaschewski and Ruth McAdam. These partnerships exemplify the collaborative spirit of innovation, allowing for the integration of diverse skills and expertise in the development of her inventions.
Conclusion
In summary, Susannah Karen Ford stands out as an accomplished inventor whose contributions to antibody technology and disease treatment have profound implications for medical science. Her dedication to innovation, coupled with her successful collaborations, continues to inspire future advancements in the field.